Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 12,900
Avg Vol 301,974
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 32%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada. The company also undertakes planned clinical trial for research into the use of ibogaine for addiction treatment. Universal Ibogaine Inc. is headquartered in Calgary, Canada.

Industry: Biotechnology
Sector: Healthcare
Phone: 855-426-4246
Address:
815 8th Avenue SW, Suite 600, Calgary, Canada
Latest News on IBOGF
No data available.